or Try an Advanced Search...

    ETF Components for BBC - Virtus LifeSci Biotech Clinical Trials ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    SRRK B -0.07 2.42
    LBPH A -0.05 2.35
    SMMT C 2.15 1.90
    WVE B 0.88 1.80
    IGMS B -5.37 1.57
    EWTX B 1.28 1.52
    VRDN B 3.29 1.40
    APLT A 2.83 1.34
    CNTA A 4.19 1.23
    ACLX B 2.25 1.22
    NRIX B -0.45 1.19
    PCVX C 0.88 1.19
    TYRA F -1.74 1.14
    VKTX A 0.47 1.11
    KYMR C 0.65 1.10
    PTGX B 2.01 1.08
    SAVA D 1.57 1.08
    ANAB F 0.23 1.05
    BLTE A 4.94 1.05
    COGT B 2.00 1.05
    ELVN B -0.79 1.04
    ABUS D 2.99 1.01
    REPL B 1.19 1.00
    CRNX B 1.30 0.99
    JANX A 0.74 0.99
    ANNX B -0.55 0.98
    QURE B 2.45 0.97
    KROS A 3.27 0.95
    RVMD A 2.97 0.94
    DNLI C 4.20 0.94
    IRON D 5.15 0.93
    PHVS A -2.90 0.93
    ERAS C 5.02 0.93
    NUVL D 0.82 0.93
    AKRO A 4.87 0.92
    PLRX A 3.20 0.90
    IMVT F 0.44 0.90
    RNA C -0.92 0.89
    ORIC D 0.32 0.87
    XENE C 1.41 0.87
    MLYS B 0.52 0.85
    VERA A 8.52 0.84
    CGON F 1.07 0.83
    RCUS F 1.31 0.83
    CELC D -3.68 0.81
    BCYC D -3.13 0.80
    ARVN C 1.78 0.80
    VERV C 3.49 0.80
    ALLO D 6.46 0.79
    XNCR A 1.19 0.78
    CYTK F 1.61 0.78
    AUTL D 3.86 0.77
    ALEC D 2.03 0.74
    OLMA F 0.78 0.74
    DYN F -0.42 0.73
    CMPS F -0.21 0.73
    SLN F 2.20 0.72
    SNDX F 0.64 0.72
    ARQT D 4.33 0.71
    MRUS C 0.74 0.71
    BEAM F 4.66 0.69
    TERN D 1.17 0.67
    ETNB D 17.48 0.66
    LRMR C -5.90 0.65
    LQDA C 1.20 0.65
    SVRA D -0.96 0.65
    KURA F 0.96 0.65
    ABCL C 0.00 0.64
    RLAY F 3.64 0.62
    NUVB F 4.07 0.61
    MGNX C 5.74 0.61
    CLDX F -1.46 0.61
    PRTA F -2.06 0.60
    IMNM F 1.05 0.59
    IDYA F 1.60 0.59
    ARWR F 1.35 0.59
    RCKT F 1.98 0.59
    RGNX F 2.33 0.58
    IMTX F 2.53 0.58
    CGEM F 1.48 0.57
    VIR B 23.63 0.56
    CVAC F 0.73 0.54
    STOK C 4.05 0.54
    RXRX F 1.27 0.53
    NTLA F 4.15 0.48
    ARCT F 1.52 0.47
    EDIT F 0.34 0.46
    ITOS F 4.26 0.42
    PGEN F 3.63 0.42
    PRME C 3.87 0.42
    SANA F 4.57 0.42
    TSHA F -9.47 0.37
    FULC F 1.58 0.33
    LYEL F 16.63 0.33
    ZNTL D 21.61 0.26
    FDMT F 1.06 0.26
    CABA F 4.51 0.24
    ALXO F 1.40 0.14
    SCLX D 1.16 0.12
    HLVX C 3.31 0.10
    AVTE C 13.88 0.07

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Life Sciences Biology Immunology Disease Immune System Solid Tumors Antibodies Organ Systems Treatment Of Cancer Autoimmune Disease Genetics Molecular Biology Monoclonal Antibodies Monoclonal Antibody Acute Myeloid Leukemia
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - General Drug Manufacturers - Specialty & Generic Medical Care Facilities

    Recent News for Virtus LifeSci Biotech Clinical Trials ETF & its Holdings

    Date Stock Title
    Nov 2 VIR Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations
    Nov 1 JANX Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
    Nov 1 RXRX Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider
    Nov 1 ALXO ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
    Nov 1 CMPS Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
    Nov 1 VIR Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
    Nov 1 VKTX Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    Nov 1 ETNB Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    Nov 1 LYEL LiveOne Leads The Pack Of 3 US Penny Stocks
    Nov 1 IRON Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
    Nov 1 VIR Vir Biotechnology Q3 2024 Earnings Preview
    Nov 1 MGNX Discover Alpha Tau Medical And 2 Other US Penny Stocks
    Nov 1 CMPS Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
    Nov 1 KYMR Kymera Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 1 KYMR Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
    Nov 1 VIR Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago
    Nov 1 LQDA Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know
    Nov 1 STOK Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
    Nov 1 ALLO Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline
    Nov 1 XNCR Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect?
    The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
    Biotechnology Health Sciences Drug Discovery Pharmacology Clinical Research Clinical Trial
    Back to the Main BBC Page...